Biomimetic modeling of oxidative drug metabolism : Strategies, advantages and limitations.
about
Immobilized Lignin Peroxidase-Like Metalloporphyrins as Reusable Catalysts in Oxidative Bleaching of Industrial DyesElectrochemistry-mass spectrometry unveils the formation of reactive triclocarban metabolitesUnexpected benzimidazole ring formation from a quinoneimide species in the presence of ammonium acetate as supporting electrolyte used in the coupling of electrochemistry with mass spectrometry.Active-site residues move independently from the rest of the protein in a 200 ns molecular dynamics simulation of cytochrome P450 CYP119.Online electrochemistry/mass spectrometry in drug metabolism studies: principles and applications.Paracetamol metabolism and related genetic differences.Mass spectrometric methods for monitoring redox processes in electrochemical cellsElectrophoretic separation techniques and their hyphenation to mass spectrometry in biological inorganic chemistry.Antioxidant Properties and Oxidative Transformation of Different Chromone Derivatives.Preparative microfluidic electrosynthesis of drug metabolites.Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors.Jacobsen catalyst as a cytochrome P450 biomimetic model for the metabolism of monensin APeroxide-dependent analyte conversion by the heme prosthetic group, the heme Peptide "microperoxidase-11" and cytochrome C on chitosan capped gold nanoparticles modified electrodes.Investigation of the biotransformation of melarsoprol by electrochemistry coupled to complementary LC/ESI-MS and LC/ICP-MS analysis.On-line electrochemistry/liquid chromatography/mass spectrometry for the simulation of pesticide metabolism.Electrochemical simulation of biotransformation reactions of citrinin and dihydroergocristine compared to UV irradiation and Fenton-like reaction.Use of an electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing.Online Investigation of Aqueous-Phase Electrochemical Reactions by Desorption Electrospray Ionization Mass Spectrometry.Structural characterization of electrochemically and in vitro biologically generated oxidation products of atorvastatin using UHPLC/MS/MS.Phase I and phase II reductive metabolism simulation of nitro aromatic xenobiotics with electrochemistry coupled with high resolution mass spectrometry.Efficient Catalytic Oxidation of 3-Arylthio- and 3-Cyclohexylthio-lapachone Derivatives to New Sulfonyl Derivatives and Evaluation of Their Antibacterial Activities.Electrochemical simulation of phase I metabolism for 21 drugs using four different working electrodes in an automated screening setup with MS detection.A ferrocene-based reagent for the conjugation and quantification of reactive metabolites.Oxidation of diclofenac catalyzed by manganese porphyrins: synthesis of novel diclofenac derivativesGlutathione trapping of reactive drug metabolites produced by biomimetic metalloporphyrin catalysts
P2860
Q26741841-156FA5A7-0A17-478A-BF9E-7ADC17E87B1DQ28384863-018FC586-5D9F-4288-8621-E0C50C8DCFBEQ30992211-15C442F2-DA1C-4D62-B1BC-E90785DD8A16Q34904359-2178BF5F-D6F9-4BEF-86E0-99E889199CF6Q37724884-FD43F85F-D014-4BB7-83E7-A245751FF72BQ37812385-9E16F35A-49E4-40E9-9034-52E6B5DCEA80Q38171385-083A5612-C2C8-4430-B3CC-8030DF3EBC09Q38661389-E5EC22E4-CA33-4654-A182-64E7F954911FQ38708659-A44D5B69-4651-4D70-A293-4D1EE2A5E3ABQ39778009-E8CFC9B1-5B3E-472E-AD8A-190BF4DBB586Q39959226-0B356070-0D2B-49D4-984B-FAB5F5ED7E78Q40734856-6102A499-B7E7-4E62-BCFA-55E28A24E4B8Q41899168-A0E44F5B-1A1F-4B57-8132-E6540A60993EQ43482385-7AD4CC53-7C6E-49D3-8437-DCDD08773786Q46325734-119D9F69-DEF1-43BE-B98A-7A3482D20178Q46380509-200B43C6-9B88-4EE3-8673-FDACCDACD177Q46425448-DA9B629D-EF4F-4591-B5B0-0943C9D80788Q46690066-D4CAD7E7-E688-478C-870F-3BD2140CDFA9Q46790873-CEACD032-F4D4-4608-8FEA-680707F919BDQ46836944-2026F4F0-60C6-4596-A1F9-A4BEC267D8A0Q52718827-F3855015-62BD-46C1-A3D0-95EEC775E5C1Q53388567-E758A3C4-4A9A-40FA-9F61-E5BF7EC89256Q54639254-FE0978CF-D0B3-4A35-9E75-7EA501142B15Q57990429-4BEABEA8-61F5-4E69-8312-33848FA62552Q58734650-843287F6-CC54-4A03-8628-86A3E0424082
P2860
Biomimetic modeling of oxidative drug metabolism : Strategies, advantages and limitations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomimetic modeling of oxidati ...... s, advantages and limitations.
@en
Biomimetic modeling of oxidati ...... s, advantages and limitations.
@nl
type
label
Biomimetic modeling of oxidati ...... s, advantages and limitations.
@en
Biomimetic modeling of oxidati ...... s, advantages and limitations.
@nl
prefLabel
Biomimetic modeling of oxidati ...... s, advantages and limitations.
@en
Biomimetic modeling of oxidati ...... s, advantages and limitations.
@nl
P1476
Biomimetic modeling of oxidati ...... s, advantages and limitations.
@en
P2093
Wiebke Lohmann
P2888
P356
10.1007/S00216-007-1794-X
P407
P577
2007-12-29T00:00:00Z